Josep Llovet of the Mount Sinai School of Medicine in New York had a similar outcome with sorafenib, an agent aimed at a protein that promotes blood-vessel growth.
纽约西奈山医学院的约瑟·劳威特(音译，Josep Llovet)用索拉非尼取得了类似的结果，它是一种针对促进血管生长的蛋白的药剂。
Josep Llovet of the Mount Sinai School of Medicine in New York had a similar outcome with sorafenib, an agent aimed at a protein that promotes blood-vessel growth.
纽约西奈山医学院的约瑟·劳威特(音译，Josep Llovet)用索拉非尼取得了类似的结果，它是一种针对促进血管生长的蛋白的药剂。
应用推荐